The ability to engineer functional vascular networks remains one of the most challenging yet essential goals in tissue engineering and regenerative medicine. Without a built‑in blood supply, thick engineered tissues cannot survive after implantation due to lack of oxygen and nutrients. Microfabricated channels—precisely engineered micro‑scale pathways—offer a powerful strategy to guide the formation of artificial vasculature by mimicking the physical cues that natural blood vessels use during development. By controlling channel geometry, surface chemistry, and mechanical properties, researchers can direct endothelial cell migration, alignment, and lumen formation, thereby creating perfusable networks that integrate with host circulation. This article reviews the key techniques for fabricating microchannels, the biological mechanisms they exploit, their current applications, and the remaining hurdles to clinical translation.

Microfabricated Channels: Precision Tools for Vascular Engineering

Natural blood vessels form through a combination of angiogenesis (sprouting from existing vessels) and vasculogenesis (de novo assembly of endothelial cells). These processes rely on a complex interplay of chemical gradients, extracellular matrix (ECM) interactions, and physical forces. Microfabricated channels replicate many of these cues in a controlled, reproducible manner. Typically created from materials such as polydimethylsiloxane (PDMS), hydrogels (e.g., collagen, fibrin, gelatin methacryloyl), or biodegradable polymers, these channels can be designed with diameters ranging from tens to hundreds of micrometers—matching the scale of capillaries, arterioles, and venules. The ability to pattern channels in two‑dimensional (2D) planar layouts or three‑dimensional (3D) networks allows researchers to construct vascular architectures that closely resemble native tissue, providing a physical scaffold that guides cellular self‑organization.

Fabrication Techniques and Material Considerations

Several advanced microfabrication methods have been adapted from the semiconductor and microelectromechanical systems (MEMS) industries to create vascular‑scale channels. The choice of technique depends on the required resolution, material, three‑dimensionality, and compatibility with cell culture.

Soft Lithography

Soft lithography remains the most widely used method for fabricating microfluidic channels in tissue engineering. It involves creating a master mold using photolithography on a silicon wafer, then casting an elastomer—typically PDMS—over the mold to produce a patterned slab after curing. PDMS is transparent, gas‑permeable, and biocompatible, making it ideal for observing cell behavior. Channels as narrow as 1 µm can be replicated with high fidelity. Researchers can bond PDMS channels to glass or other substrates to form closed conduits. A major limitation is that PDMS does not degrade, so it is primarily used for in vitro models or as a sacrificial template for hydrogels.

To create biodegradable scaffolds, soft lithography can be applied to natural or synthetic hydrogels by replica molding of sacrificial materials (e.g., gelatin, alginate, or Pluronic F‑127). After the hydrogel is cross‑linked, the sacrificial template is dissolved or thermally removed, leaving behind a hollow channel network. This approach has been used to produce perfusable channels in collagen and fibrin gels.

Photolithography

Photolithography uses light to transfer a geometric pattern from a photomask to a photosensitive material (photoresist) on a substrate. Traditional photolithography produces 2D patterns, but stacking multiple layers or using inclined exposure can create rudimentary 3D structures. Recent advances in two‑photon polymerization enable direct writing of 3D microchannels with sub‑micrometer resolution inside a photosensitive resin. This technique can generate complex branching geometries, including bifurcations and curved vessels, that closely mimic natural vascular trees. The main drawbacks are the high cost, slow speed (writing serially), and limited material options (mostly acrylic‑based photoresists that may not be optimal for cell culture).

3D Bioprinting

Extrusion‑based and ink‑jet bioprinting have emerged as flexible methods for fabricating vascular‑like channels within cell‑laden hydrogels. By printing a sacrificial ink (e.g., gelatin, Pluronic, or carbohydrate glass) in a desired pattern, then encapsulating it with a bulk hydrogel and subsequently removing the sacrificial material, researchers can create perfusable networks. This approach allows patient‑specific geometries and integration of multiple cell types. For example, the Lee group at Rice University used a 3D‑printed carbohydrate glass lattice to create a vascular network in a fibrin matrix that supported endothelial cell lining and red blood cell flow. Limitations include resolution (typically 200–500 µm) and the need to ensure that the sacrificial material is completely removed without damaging the surrounding cells.

Laser Ablation

Femtosecond laser ablation can carve microchannels inside hydrogels or even living tissues with high precision. The laser pulses vaporize material locally, creating channels as small as a few micrometers in diameter. This method does not require a mold or sacrificial template and can produce arbitrary 3D paths. It is especially useful for fabricating channels in dense collagen matrices or in decellularized tissue scaffolds. However, the process can generate heat and debris that may harm nearby cells, and it is time‑consuming for large volumes. Despite these challenges, laser ablation has been used to create capillary‑sized networks in vitro and to connect microchannels to larger feeding vessels.

Guiding Cellular Behavior Through Microchannel Design

The success of microchannel‑guided vascularization depends on how well the physical and chemical features of the channels replicate the native microenvironment. Endothelial cells (ECs) sense topography, stiffness, and shear stress, and they respond by reorganizing their cytoskeleton, polarizing, and forming lumen structures.

Physical Cues: Topography, Geometry, and Stiffness

Channel width, height, and curvature dictate the alignment of ECs. Straight channels promote uniaxial alignment, while bifurcations encourage sprouting. Channels with diameters below 50 µm force ECs to form a monolayer lining the inner wall, producing a patent lumen. The so‑called “contact guidance” effect is mediated by integrin‑based adhesions to the channel surface. If the surface is patterned with ridges or grooves (e.g., via nanoimprinting), ECs align even more strongly. Matrix stiffness also matters: on soft substrates (0.5–5 kPa, typical of brain and fat), ECs form more stable networks; on stiff substrates (>50 kPa, like bone), they tend to spread and form monolayers.

Shear stress from fluid flow is another critical physical cue. When perfused at physiological flow rates (0.5–10 dyn cm⁻²), ECs upregulate genes associated with vessel homeostasis, such as KLF2 and eNOS, and they align in the direction of flow. Microchannels enable precise control of flow rate and pressure, allowing researchers to study shear‑dependent angiogenesis and barrier function.

Biochemical Cues: Growth Factor Gradients

Natural angiogenesis is driven by gradients of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and angiopoietins. Microchannels can be modified to present these factors in a spatially controlled manner—for example, by embedding growth‑factor‑loaded microparticles in the channel walls or by using a microfluidic gradient generator. Coating channel surfaces with adhesive proteins like fibronectin or collagen IV promotes EC attachment and prevents anoikis. Some groups have engineered channels that release VEGF in response to matrix metalloproteinase (MMP) activity, mimicking the dynamic environment of sprouting vessels.

Cell‑Matrix Interactions

ECM composition inside and around the channel plays a dual role: it provides structural support and presents biochemical signals. Channels fabricated in hydrogels rich in collagen I and fibrin support robust EC proliferation and sprouting because these matrices contain integrin‑binding sites (e.g., RGD sequences) and are readily remodeled by cell‑derived MMPs. In contrast, synthetic hydrogels (e.g., PEG‑based) must be functionalized with adhesive peptides and MMP‑cleavable cross‑linkers to enable cell invasion and network formation. Microchannels also allow co‑culture with mural cells (pericytes, vascular smooth muscle cells) in a spatially defined manner—embedding pericytes in the bulk hydrogel near the channel promotes vascular stabilization and lumen maturation.

Formation of Functional Vascular Networks

Once cells are seeded and the channels are perfused, a series of cellular events leads to the formation of a connected, functional vascular network.

Endothelial Cell Alignment and Lumenogenesis

Within hours of seeding, ECs adhere to the microchannel walls and begin to elongate. Over the next 1–3 days, they form a confluent monolayer lining the entire channel. In channels wider than ~50 µm, ECs may initially cover the floor and ceiling, eventually bridging to create a cylindrical lumen. The formation of a continuous, tight‑junction‑sealed monolayer is essential for barrier function. Studies using the “vessel‑on‑a‑chip” platform by the Ingber lab have demonstrated that ECs in microchannels develop functional adherens junctions (VE‑cadherin) and tight junctions (claudin‑5), and they exhibit selective permeability to solutes of different sizes.

Pericyte Recruitment and Vascular Maturation

For long‑term stability, capillaries must be wrapped by pericytes or smooth muscle cells. Microchannels made in hydrogels can incorporate these mural cells in the surrounding matrix. When the medium contains platelet‑derived growth factor‑BB (PDGF‑BB), pericytes migrate toward the EC‑lined channel and extend processes that contact the endothelial tube. This interaction triggers the deposition of basement membrane proteins (laminin, collagen IV) and reduces EC proliferation—signs of vascular maturation. Some groups have used two‑photon laser ablation to create channels of varying sizes and then co‑cultured pericytes, observing that small channels (30 µm) recruit more pericytes than large ones, likely due to higher local concentrations of PDGF from the ECs.

Perfusion and Anastomosis

Ultimately, the engineered vascular network must connect to the host circulation (if implanted) or to additional fluidic ports (for in vitro models). Microchannels are often designed with inlet and outlet ports for continuous perfusion. In in vivo applications, an engineered channel can be surgically anastomosed to an artery and vein. For example, in a rat model, a microchannel‑containing hydrogel implant was successfully connected to the femoral vessels and remained perfused for weeks. In vitro, connecting multiple microchannels to a larger reservoir allows researchers to test drug transport and shear‑dependent responses in a high‑throughput manner.

Applications in Tissue Engineering and Disease Modeling

Microfabricated channel systems are not just research tools—they have practical applications that span drug development, disease biology, and regenerative therapies.

Organ‑on‑a‑Chip Platforms

The most mature application is the “vessel‑on‑a‑chip” or “organ‑on‑a‑chip” format, where microchannels lined with ECs are integrated with other organ‑specific cells (e.g., hepatocytes, cardiomyocytes, lung epithelial cells). These platforms recapitulate the microarchitecture and function of human organs, enabling realistic drug testing and toxicity screening. A notable example is the lung‑on‑a‑chip developed by the Wyss Institute, which contains two parallel microchannels separated by a porous membrane—one lined with lung epithelial cells and the other with lung capillary ECs. By applying cyclic stretch, this model mimics breathing mechanics and has been used to study pulmonary edema and drug responses.

Drug Screening and Toxicology

Microchannels provide a controlled environment for studying vascular‑targeted therapies. Researchers can perfuse drugs through the channel and measure endothelial barrier integrity, angiogenesis inhibition (e.g., by anti‑VEGF drugs), or thrombus formation. The small volume of microfluidic systems reduces reagent consumption and enables high‑content imaging. Assays for vascular permeability (using fluorescent dextran) and angiogenic sprouting (from a central channel into a hydrogel‑filled side channel) are now standard in many labs.

Vascularized Tissue Grafts

For regenerative medicine, the ultimate goal is to create a thick, implantable tissue construct that is pre‑vascularized using microchannels. Pre‑vessel networks can be lined with patient‑derived ECs and then surgically connected to the host vasculature, reducing the time needed for host vessel ingrowth (which often fails due to hypoxia). Recent work has demonstrated that microchannel‑containing hydrogels seeded with ECs and smooth muscle cells can form functional vessels that remain patent for weeks after implantation in mice. Such constructs hold promise for repairing ischemic tissues, reconstructing large bone defects, or creating vascularized skin grafts for burns.

Challenges and Future Directions

Despite remarkable progress, several obstacles remain before microchannel‑guided vascularization becomes a routine clinical tool.

Scalability: Most current fabrication methods produce small (mm‑size) samples with a limited number of channels. Creating a vascular network that matches the density and complexity of a human organ (e.g., liver or kidney) will require high‑throughput, automated techniques. 3D bioprinting is scaling up, but resolution and speed are still trade‑offs.

Long‑term stability: EC‑lined channels in hydrogels often degrade over weeks due to cell‑mediated ECM remodeling. Balancing matrix cross‑linking to allow remodeling while preventing collapse is difficult. Co‑culture with pericytes improves stability, but achieving long‑term (>1 month) patency comparable to native vessels remains a challenge.

Integration with host vasculature: When implants are anastomosed, there is often a mismatch in mechanical properties (stiffness) and biochemical signals, leading to thrombosis or intimal hyperplasia. Surface engineering (e.g., coating with heparin or anti‑inflammatory peptides) may reduce clot formation. Better strategies for inducing robust anastomosis in situ are needed.

Heterotypic cell interactions: Real vascular networks are surrounded by multiple cell types (fibroblasts, macrophages, nerve cells) that modulate vessel behavior. Incorporating these cells in a spatially controlled manner within microchannel scaffolds will be essential for in vivo relevance.

Standardization and reproducibility: Different labs use different fabrication protocols and materials, making it difficult to compare results. The development of standard operating procedures, validated cell lines, and commercially available microchannel scaffolds would accelerate translation.

Conclusion

Microfabricated channels provide a versatile and powerful platform for directing vascular network formation. By combining precise geometric control with biochemical functionality, researchers can recreate key aspects of natural angiogenesis and produce functional, perfusable vessels both in vitro and in vivo. The field has moved from proof‑of‑concept demonstrations to sophisticated organ‑on‑a‑chip models and early therapeutic implants. Continued advances in fabrication scalability, material design, and cellular complexity will likely bring microchannel‑based vascularization closer to clinical reality—enabling better tissue grafts, more predictive drug testing, and deeper insights into vascular biology.